Clinical trial · Interventional
Decision Counseling Program in Increasing Shared Decision Making and Clinical Trial Participation in Patients With Stage 0-IV Lung Cancer (Free to Breathe)
Increasing Shared Decision Making and Patient Participation in Lung Cancer Clinical Trials (Free to Breathe)
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This clinical trial studies how well the Decision Counseling Program works in increasing patient-physician shared decision making and participation in clinical trials for lung cancer patients. Decision aids help provide patients with information that may help them select a course of action related to their cancer care when more than one alternative is available. It also encourages shared decision making allowing patients and their providers to make health decisions together. Determining how patients make decisions about participating in a clinical trial may help doctors facilitate patient decision making and improve participation in lung cancer clinical trials.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Educational Intervention | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Decision Counseling
- description
- Patients undergo participation in the DCP prior to an audio-recorded oncology appointment.
- interventionNames
- Other: Educational Intervention
Primary outcomes (1)
- measure
- Patient perception related to clinical trials participation, measured by follow up survey questions
- timeFrame
- Baseline to 30 days
- description
- Will compute descriptive statistics for all sections and determine the variables on which to compare patient responses at the two time points (baseline and endpoint) using paired t-tests.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients diagnosed with lung cancer (Stages 0, 1, 2, 3, 4) * Lung cancer patients for which there is an available interventional clinical trial open at Jefferson Kimmel Cancer Center * Patients being treated by a lung medical oncologist on the Center City Campus of Thomas Jefferson University * Able to provide informed consent * English-speaking Exclusion Criteria: * Inability to communicate in English * Unable to provide informed consent * Not eligible for an open, actively accruing interventional trial at Jefferson
References
Publications (0)
Data not yet available